1 |
Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond[J]. J Am Coll Cardiol, 2019, 74(20): 2529-2532.
|
2 |
GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017[J]. Lancet, 2018, 392(10159): 1859-1922.
|
3 |
王媛, 曹新西, 侯亚冰, 等. 1990和2017年中国与全球心血管病疾病负担研究[J].中国慢性病预防与控制, 2020, 28(1): 10-13, 19.
|
4 |
王芳旭, 陶立波.超高危动脉粥样硬化性心血管疾病的疾病负担和药物研究进展[J].中国药物经济学, 2020, 15(10): 14-18.
|
5 |
Gan LM, Wikström J, Fritsche-Danielson R. Coronary flow reserve from mouse to man: from mechanistic understanding to future interventions[J]. J Cardiovasc Transl Res, 2013, 6(5): 715-728.
|
6 |
Zeymer U, Bueno H, Granger CB, et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: a document of the Acute Cardiovascular Care Association of The European Society of Cardiology[J]. Eur Heart J Acute Cardiovasc Care, 2020, 9(2): 183-197.
|
7 |
He W, Cao M, Li Z. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI)[J]. Drug Dev Res, 2020, 81(5): 551-556.
|
8 |
Chang K, Ahn Y, Lim S, et al. 2021 Korean society of myocardial infarction expert consensus document on revascularization for acute myocardial infarction[J]. Korean Circ J, 2021, 51(4): 289-307.
|
9 |
Bugger H, Pfeil K. Mitochondrial ROS in myocardial ischemia reperfusion and remodeling[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(7): 165768.
|
10 |
Peet C, Ivetic A, Bromage DI, et al. Cardiac monocytes and macrophages after myocardial infarction[J]. Cardiovasc Res, 2020, 116(6): 1101-1112.
|
11 |
Marzilli M, Merz CN, Boden WE, et al. Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link![J]. J Am Coll Cardiol, 2012, 60(11): 951-956.
|
12 |
Zhao Y, Zhang X, Luan J, et al. Shenxian-Shengmai oral liquid reduces myocardial oxidative stress and protects myocardium from ischemia-reperfusion injury[J]. Cell Physiol Biochem, 2018, 48(6): 2503-2516.
|
13 |
Cadenas S. ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection[J]. Free Radic Biol Med, 2018, 117: 76-89.
|
14 |
Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species[J]. Biochim Biophys Acta, 2016, 1863(12): 2977-2992.
|
15 |
Hausenloy DJ, Garcia-Dorado D, Bøtker HE, et al. Novel targets and future strategies for acute cardioprotection: position paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart[J]. Cardiovasc Res, 2017, 113(6): 564-585.
|
16 |
Hamley IW. Small bioactive peptides for biomaterials design and therapeutics[J]. Chem Rev, 2017, 117(24): 14015-14041.
|
17 |
Fosgerau K, Hoffmann T. Peptide therapeutics: current status and future directions[J]. Drug Discov Today, 2015, 20(1): 122-128.
|
18 |
Wang W, Zheng Y, Jia J, et al. Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1[J]. Exp Ther Med, 2017, 14(1): 499-506.
|
19 |
Gilon C, Gitlin-Domagalska A, Lahiani A, et al. Novel humanin analogs confer neuroprotection and myoprotection to neuronal and myoblast cell cultures exposed to ischemia-like and doxorubicin-induced cell death insults[J]. Peptides, 2020, 134: 170399.
|
20 |
Goetze JP, Bruneau BG, Ramos HR, et al. Cardiac natriuretic peptides[J]. Nat Rev Cardiol, 2020, 17(11): 698-717.
|
21 |
Wu L, Li H, Li X, et al. Peptidomic analysis of cultured cardiomyocytes exposed to acute ischemic-hypoxia[J]. Cell Physiol Biochem, 2017, 41(1): 358-368.
|
22 |
Szabo D, Sarszegi Z, Polgar B, et al. PACAP-38 in acute ST-segment elevation myocardial infarction in humans and pigs: A translational study[J]. Int J Mol Sci, 2021, 22(6): 2883.
|
23 |
Nakamura S, Pourkheirandish M, Morishige H, et al. Mitogen-activated protein kinase Kinase 3 regulates seed dormancy in barley[J]. Curr Biol, 2016, 26(6): 775-781.
|
24 |
Sun Y, Liu WZ, Liu T, et al. Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis[J]. J Recept Signal Transduct Res, 2015, 35(6): 600-604.
|
25 |
Liao B, Chen R, Lin F, et al. Imperatorin protects H9c2 cardiomyoblasts cells from hypoxia/reoxygenation-induced injury through activation of ERK signaling pathway[J]. Saudi Pharm J, 2017, 25(4): 615-619.
|
26 |
Mao S, Luo X, Li Y, et al. Role of PI3K/AKT/mTOR pathway associated oxidative stress and cardiac dysfunction in takotsubo syndrome[J]. Curr Neurovasc Res, 2020, 17(1): 35-43.
|
27 |
Sung SM, Jung DS, Kwon CH, et al. Hypoxia/reoxygenation stimulates proliferation through PKC-dependent activation of ERK and Akt in mouse neural progenitor cells[J]. Neurochem Res, 2007, 32(11): 1932-1939.
|
28 |
Gil-Gómez G, Berns A, Brady HJ. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis[J]. EMBO J, 1998, 17(24): 7209-7218.
|
29 |
Wang Y, Chen Y, Cheng X, et al. Design, synthesis and biological evaluation of pyrimidine derivatives as novel CDK2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells[J]. Bioorg Med Chem, 2018, 26(12): 3491-3501.
|
30 |
Filippou A, Pehkonen H, Karhemo PR, et al. ANO1 expression orchestrates p27Kip1/MCL1-mediated signaling in head and neck squamous cell carcinoma[J]. Cancers (Basel), 2021, 13(5): 1170.
|
31 |
Takahashi R, Kawawa A, Kubota S. Short time exposure to hypoxia promotes H9c2 cell growth[J]. Biochim Biophys Acta, 2006, 1760(9): 1293-1297.
|